Funding
← Back to your selection

Sanofi Ventures

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Sep 18, 2026
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$310M
1 disclosed · full round size, not this investor’s share

By stage

Series C+1

By primary sector

Biotech1

By country

United Kingdom1

Rounds

1 in this selection
OMass Therapeutics

OMass Therapeutics develops small-molecule medicines for endocrine and immune diseases using a platform that measures drug targets in their biological surroundings.

$310MSeries C
Participant